NEFL and myeloid sarcoma: We comparatively investigated the biomarker utility of 2 potential biomarkers of MS acting through diverse biological mechanisms: NFL, a well-established marker of neuro-axonal loss and unfavorable prognosis in MS [4], and BDNF, a neuroprotective mediator also representing antiinflammatory glial activity [11].